Maravai Lifesciences Holdings (MRVI) Enterprise Value Growth (1y) (2021 - 2026)
Maravai Lifesciences Holdings (MRVI) Enterprise Value Growth (1y) (2021 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | Maravai Lifesciences Holdings | 727.74 Mn | 719.33 Mn | 33.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 84.83% |
| Dec 31, 2025 | 21.29% |
| Sep 30, 2025 | 81.58% |
| Jun 30, 2025 | 71.99% |
| Mar 31, 2025 | 71.59% |
| Dec 31, 2024 | 64.40% |
| Sep 30, 2024 | -50.21% |
| Jun 30, 2024 | -19.14% |
| Mar 31, 2024 | -151.42% |
| Dec 31, 2023 | 25.83% |
| Sep 30, 2023 | -161.15% |
| Jun 30, 2023 | -164.03% |
| Mar 31, 2023 | 39.51% |
| Dec 31, 2022 | -218.38% |
| Sep 30, 2022 | 121.14% |
| Jun 30, 2022 | 124.06% |
| Mar 31, 2022 | 172.60% |
| Dec 31, 2021 | 247.04% |